Decitabine
- Product NDC
- 69097-285
- 11-digit product format
- 690970285
- Labeler code
- 69097
- Product ID
- 69097-285_09f6cad4-9a16-4266-bedb-72fc6194328a
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Decitabine
- Dosage form
- INJECTION
- Route
- INTRAVENOUS
- Labeler
- Cipla USA Inc.
- Application
- ANDA208601
- Marketing category
- ANDA
- Marketing start
- 2017-11-16
- Marketing end
- 0000-00-00
- Substance
- DECITABINE
- Active strength
- 50 mg/10mL
- Pharmacologic classes
- Nucleic Acid Synthesis Inhibitors [MoA],Nucleoside Metabolic Inhibitor [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2021-12-31
- Current FDA listing
- Historical FDA.report record
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 69097-285-37 | 69097028537 | 1 VIAL, SINGLE-USE in 1 CARTON (69097-285-37) > 10 mL in 1 VIAL, SINGLE-USE | 2017-11-16 | 0000-00-00 | No | No | Current |